# Clinical Cases: Tubulointerstitial Diseases

## Case 1: Drug-Induced Acute Interstitial Nephritis

### Patient Presentation
**Demographics:** 45-year-old female

**Chief Complaint:** Elevated creatinine found on routine labs

**History of Present Illness:**
The patient was started on omeprazole 20 mg daily 2 months ago for gastroesophageal reflux disease. She presents for routine follow-up and is found to have elevated creatinine. She reports mild fatigue and occasional bilateral flank discomfort but denies fever, rash, dysuria, or gross hematuria. She had no prior kidney disease.

**Past Medical History:**
- GERD (recently diagnosed)
- Hypertension
- No prior kidney disease

**Medications:**
- Omeprazole 20 mg daily (started 2 months ago)
- Lisinopril 10 mg daily (stable for years)

**Physical Examination:**
- Blood pressure: 132/82 mmHg
- Temperature: 37.0C
- General: Well-appearing
- Skin: No rash
- Lungs: Clear
- Abdomen: Mild bilateral CVA tenderness
- Extremities: No edema

### Workup and Results

**Laboratory Studies:**
- Creatinine: 2.1 mg/dL (baseline 0.9 mg/dL 4 months ago)
- BUN: 28 mg/dL
- Potassium: 4.8 mEq/L
- WBC: 9,200/mcL with 8% eosinophils (736/mcL)
- Urinalysis: 1+ protein, no blood, 30 WBC/hpf, occasional WBC casts
- Urine culture: Negative
- Urine eosinophils: Present

**Renal Biopsy:**
- Interstitial edema with lymphocytic infiltrate
- Eosinophils present in interstitium
- Tubulitis
- Glomeruli: Normal
- No granulomas

### Clinical Image

![Acute Interstitial Nephritis](case_01_image.jpg)

*Renal biopsy showing acute interstitial nephritis with interstitial edema, lymphocytic infiltration, scattered eosinophils, and tubulitis (lymphocytes invading tubular epithelium).*

### Diagnosis
**Proton Pump Inhibitor-Induced Acute Interstitial Nephritis**

Features supporting diagnosis:
- Temporal relationship with PPI initiation
- Sterile pyuria with WBC casts
- Mild peripheral eosinophilia
- Biopsy confirmation

### Discussion
This case illustrates drug-induced AIN:

- **PPI-Associated AIN**: The lecture notes that PPIs have emerged as an increasingly recognized cause of AIN. Unlike beta-lactam antibiotics (1-3 week onset), PPI-induced AIN often has insidious onset weeks to months after starting therapy.

- **Classic Triad Absent**: The lecture emphasizes that the complete triad of fever, rash, and eosinophilia occurs in <10% of AIN cases. This patient had only mild eosinophilia without fever or rash.

- **Type IV Hypersensitivity**: Drug-induced AIN represents a delayed-type hypersensitivity reaction where the drug acts as a hapten, not a dose-dependent toxicity.

- **WBC Casts**: The lecture identifies WBC casts as characteristic of AIN or pyelonephritis, distinguishing interstitial from glomerular disease.

- **Urine Eosinophils**: The lecture notes urine eosinophils have low sensitivity (40-60%) but can support the diagnosis when present.

### Treatment Plan
1. **Discontinue Omeprazole:**
   - Switch to H2 blocker (famotidine) for GERD
   - Avoid all PPIs in the future

2. **Observation Period:**
   - Monitor creatinine for 1 week after drug discontinuation
   - Many patients improve with drug withdrawal alone

3. **Corticosteroids (if no improvement):**
   - Prednisone 1 mg/kg/day for 2-4 weeks
   - Taper over 4-6 weeks
   - Consider if no improvement within 1 week

4. **Follow-up:**
   - Creatinine improved to 1.2 mg/dL at 4 weeks
   - Document PPI allergy in medical record

### Teaching Points
1. PPIs cause AIN with delayed onset (weeks to months)
2. Classic triad of fever, rash, eosinophilia is present in <10% of cases
3. WBC casts and sterile pyuria suggest interstitial nephritis
4. Withdrawal of offending agent is the cornerstone of treatment

---

## Case 2: Gitelman Syndrome

### Patient Presentation
**Demographics:** 22-year-old female

**Chief Complaint:** Muscle cramps and fatigue

**History of Present Illness:**
The patient has experienced recurrent muscle cramps, fatigue, and occasional palpitations since adolescence. She was recently evaluated for hypertension but was found to have consistently low blood pressure. She craves salty foods. She denies diuretic use, vomiting, or diarrhea.

**Family History:**
- Brother with similar symptoms and low potassium

**Physical Examination:**
- Blood pressure: 98/62 mmHg
- Heart rate: 72 bpm
- General: Thin, healthy-appearing
- Cardiovascular: Regular rhythm, no murmurs
- Neurologic: Slight muscle weakness proximally
- No edema

### Workup and Results

**Laboratory Studies:**
- Creatinine: 0.8 mg/dL
- Potassium: 2.8 mEq/L (low)
- Magnesium: 1.2 mg/dL (low)
- Bicarbonate: 32 mEq/L (elevated - metabolic alkalosis)
- Chloride: 94 mEq/L
- Calcium: 9.4 mg/dL
- 24-hour urine calcium: 45 mg/day (low - hypocalciuria)
- Urine potassium: 45 mEq/day (inappropriately high)
- Plasma renin activity: Elevated
- Aldosterone: Elevated

**Genetic Testing:**
- SLC12A3 gene mutation (thiazide-sensitive NaCl cotransporter)

### Clinical Image

![Gitelman Syndrome](case_01_image.jpg)

*Diagram illustrating the distal convoluted tubule showing the NCC (thiazide-sensitive sodium-chloride cotransporter) affected in Gitelman syndrome, with the resulting electrolyte abnormalities.*

### Diagnosis
**Gitelman Syndrome**

Diagnostic criteria met:
- Hypokalemia with renal potassium wasting
- Metabolic alkalosis
- Hypomagnesemia
- Hypocalciuria (key distinguishing feature from Bartter)
- Genetic confirmation

### Discussion
This case demonstrates Gitelman syndrome:

- **Mimics Chronic Thiazide Use**: The lecture describes how Gitelman syndrome mimics chronic thiazide diuretic use because it results from loss-of-function mutations in the NCC transporter in the distal convoluted tubule.

- **Distinguishing from Bartter**: The lecture emphasizes that hypocalciuria and hypomagnesemia distinguish Gitelman from Bartter syndrome. Bartter mimics loop diuretics and causes hypercalciuria.

- **Electrolyte Pattern**: Both syndromes produce hypokalemia and metabolic alkalosis, but Gitelman is typically milder and presents later in life.

- **Compensation**: Elevated renin and aldosterone represent appropriate physiologic response to volume contraction, not primary hyperaldosteronism.

### Treatment Plan
1. **Potassium Supplementation:**
   - Potassium chloride 40-80 mEq/day in divided doses
   - Target potassium >3.0 mEq/L

2. **Magnesium Supplementation:**
   - Magnesium oxide or chloride supplements
   - Essential for correcting hypokalemia

3. **Consider Potassium-Sparing Diuretics:**
   - Amiloride or spironolactone
   - Block distal potassium secretion

4. **Dietary Modifications:**
   - High-salt diet (no restriction)
   - Potassium-rich foods

5. **Monitoring:**
   - Regular electrolyte monitoring
   - Counsel about symptoms of severe hypokalemia

### Teaching Points
1. Gitelman mimics chronic thiazide use (DCT defect)
2. Bartter mimics chronic loop diuretic use (TAL defect)
3. Hypocalciuria distinguishes Gitelman from Bartter
4. Hypomagnesemia is characteristic of Gitelman syndrome
5. Treatment focuses on electrolyte replacement

---

## Case 3: Analgesic Nephropathy

### Patient Presentation
**Demographics:** 58-year-old female

**Chief Complaint:** Chronic headache management and rising creatinine

**History of Present Illness:**
The patient has a long history of chronic daily headaches and has used over-the-counter analgesics daily for over 20 years. She estimates she has taken combination products containing acetaminophen, aspirin, and caffeine (similar to Excedrin) almost daily. She now presents with gradually declining kidney function noted over the past 2 years.

**Past Medical History:**
- Chronic daily headaches
- Hypertension (difficult to control)
- History of kidney stones
- Recurrent UTIs

**Physical Examination:**
- Blood pressure: 156/94 mmHg
- General: Well-appearing
- Cardiovascular: Regular, no murmurs
- Abdomen: Non-tender
- No edema

### Workup and Results

**Laboratory Studies:**
- Creatinine: 2.4 mg/dL (was 1.8 mg/dL 1 year ago)
- BUN: 36 mg/dL
- Potassium: 4.2 mEq/L
- Bicarbonate: 20 mEq/L (mild acidosis)
- Urinalysis: 1+ protein, no blood, WBC 5-10/hpf
- Urine concentrating ability: Impaired (max 450 mOsm/kg)

**CT Urogram:**
- Bilateral small kidneys with irregular contours
- Papillary calcifications
- "Bumpy" kidney contour suggesting papillary necrosis

### Clinical Image

![Papillary Necrosis](case_01_image.jpg)

*CT scan demonstrating bilateral small kidneys with irregular contours and papillary calcifications characteristic of analgesic nephropathy with papillary necrosis.*

### Diagnosis
**Chronic Tubulointerstitial Nephritis due to Analgesic Nephropathy**

Features:
- >20 years of daily combination analgesic use
- Bilateral small, irregular kidneys
- Papillary necrosis
- Concentrating defect
- History of UTIs and stones

### Discussion
This case illustrates analgesic nephropathy:

- **Papillary Necrosis**: The lecture describes how chronic analgesic use, particularly combination products, causes papillary necrosis. The renal papilla is particularly susceptible due to its concentrated, hypoxic environment.

- **Mechanism**: Combination products (especially those with caffeine) are more nephrotoxic than single agents. Prostaglandin inhibition leads to medullary ischemia.

- **Clinical Features**: The lecture notes that chronic tubulointerstitial disease presents with concentrating defects (polyuria, nocturia), mild proteinuria (<2 g/day), and relatively early anemia for GFR level.

- **Associated Conditions**: Analgesic nephropathy is associated with increased risk of transitional cell carcinoma of the urinary tract.

### Treatment Plan
1. **Discontinue All Analgesics:**
   - Stop combination products immediately
   - Seek alternative headache management (neurology referral)

2. **Blood Pressure Control:**
   - Target <130/80 mmHg
   - ACE inhibitor for proteinuria

3. **Supportive Care:**
   - Avoid NSAIDs
   - Adequate hydration

4. **Cancer Surveillance:**
   - Annual urinalysis and cytology
   - Increased transitional cell carcinoma risk

5. **CKD Management:**
   - Monitor progression
   - Standard CKD care

### Teaching Points
1. Analgesic nephropathy characteristically causes papillary necrosis
2. Combination analgesics (especially with caffeine) are more nephrotoxic
3. Chronic tubulointerstitial disease causes concentrating defects early
4. Aristolochic acid and analgesic nephropathy increase urothelial cancer risk

---

## Image Reference

For visual reference of tubulointerstitial disease concepts, see:
- Radiopaedia: [Acute interstitial nephritis](https://radiopaedia.org/articles/acute-interstitial-nephritis) - Pathology
- Wikimedia Commons: [Papillary necrosis](https://commons.wikimedia.org/wiki/Category:Papillary_necrosis) - Imaging
- Radiopaedia: [Papillary necrosis](https://radiopaedia.org/articles/papillary-necrosis) - CT findings

---

## Learning Points

1. **AIN Triad is Rare**: Fever, rash, and eosinophilia occur together in <10% of drug-induced AIN

2. **PPI Latency**: PPI-induced AIN has delayed onset (weeks to months) unlike antibiotics (1-3 weeks)

3. **Gitelman vs Bartter**: Hypocalciuria and hypomagnesemia distinguish Gitelman (DCT) from Bartter (TAL)

4. **TIN Features**: Mild proteinuria (<2 g/day), WBC casts, concentrating defects, disproportionate anemia

5. **Papillary Necrosis Causes**: Analgesics, diabetes, sickle cell, obstruction, pyelonephritis (mnemonic: POSTCARD - Pyelonephritis, Obstruction, Sickle cell, TB, Cirrhosis, Analgesics, Renal vein thrombosis, Diabetes)